Having trouble accessing articles? Reset your cache.

Aug. 23 P&P Quick Takes: FDA meetings on pediatric safety of OxyContin, Singulair; a vaccine meeting on Chikungunya

FDA panels to discuss pediatric safety of OxyContin, Singulair
On Sept. 26 and 27, a joint meeting of

Read the full 171 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE